Introduction {#S1}
============

How midbrain dopamine (DA) neurons underpin a spectrum of apparently unrelated behaviors and diseases is enigmatic^[@R1],[@R2]^. One possibility is that the midbrain DAergic system is composed of functionally distinct neuron subtypes. Initially, DAergic neurons were classified into three anatomically-defined midbrain clusters located in the ventral tegmental area (VTA; A10), the substantia nigra *pars compacta* (SNc; A9), and retrorubral area (RR; A8)^[@R2]^. More recently, there has been increasing evidence of functional heterogeneity within these clusters, with subsets of DA neurons influencing specific behavioral outcomes (reviewed in^[@R3]--[@R7]^). Consistent with this, several putative subtypes of midbrain DA neurons have recently been defined on their distinct combinatorial gene expression profiles^[@R8]--[@R10]^. These initial single-cell profiling based studies provide a first-generation framework for disentangling the DAergic system into its constituent parts^[@R11],[@R12]^. Key unresolved questions are whether these molecularly defined DA neuron subtypes have unique axonal projections, synaptic inputs, physiological properties, or functional roles.

The ability to genetically target DA neuron subtypes is critical for resolving these questions. Intersectional genetic paradigms exploit the expression of two or more genes with overlapping expression patterns to target a cell population with high selectivity^[@R13],[@R14]^. Here, we developed three distinct intersectional genetic strategies to target DA neuron populations with fluorescent proteins and used these strategies to determine their broad axonal projections. Our results indicate that molecularly defined DA neuron subtypes have projection patterns that, despite some overlap, are unexpectedly distinctive even within defined target regions such as the caudate-putamen, nucleus accumbens, and amygdala.

Results {#S2}
=======

Generation and validation of the Th--2A--Flpo mouse line {#S3}
--------------------------------------------------------

To develop an intersectional platform for targeting DA neurons, we generated a Flp recombinase line driven from the tyrosine hydroxylase (*Th*) locus, a gene encoding the rate limiting enzyme in DA synthesis ([Fig. 1A](#F1){ref-type="fig"}; see [Methods](#S23){ref-type="sec"}). To determine the recombination potential of the Th--2A--Flpo driver, we crossed it with the Flp dependent reporters RC::FA (nlacZ, [Fig. 1B](#F1){ref-type="fig"}) and RC::Frepe (mCherry, [Fig. S1](#SD1){ref-type="supplementary-material"})^[@R13]^. Within midbrain DA clusters, we observed reporter staining within the SNc, VTA, interfascicular (IF), RR, and caudal linear (CLi) ([Fig. 1C](#F1){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}). We found that most TH+ cells were recombined (βgal+TH+/total TH+; 99.9% ±0.01), indicating the Th-2A-Flpo line is highly efficient. We next quantified the percentage of βgal+ cell that co-express TH, and found high specificity of labeling (βgal+TH+/total βgal+; 93.0% ±0.1). The lower percentage of βgal+ cells that co-localize with TH, particularly observed in the IF, CLi and PAG/DR, is consistent with observations using Th-ires-Cre^[@R15],[@R16]^, a fact that needs to be considered in the design and interpretation of experiments. At the level of the midbrain, we also observed labeled neurons in the region englobing the rostral linear and posterior hypothalamic (RLi/PH; FOXA2+, NURR1+, *Ddc+*, *Dat*--), as well as the interpeduncular nucleus (IPN; FOXA2--, NURR1--, *Ddc*--, *Dat*--; [Fig. S2](#SD1){ref-type="supplementary-material"}). Reporter was present in most brain regions with *Th* mRNA expression, including cortical interneurons, striatal interneurons, neurons in the medial forebrain, hypothalamic DA nuclei, subsets of Purkinje neurons, and hindbrain catecholaminergic cell groups ([Fig. S3](#SD1){ref-type="supplementary-material"}).

Intersectional genetic strategies to map the projections of midbrain DA neuron subtypes {#S4}
---------------------------------------------------------------------------------------

We next devised three distinct intersectional genetic strategies to target putative DA neuron subtypes. Strategy I uses a reporter mouse that labels with tdTomato only cells that express both Cre and Flpo recombinases (Ai65)^[@R17]^ ([Fig. 2A](#F2){ref-type="fig"}). This approach is not limited by the diffusion of viral particles and therefore provides a more complete picture of the intersectional neuron population. However, one limitation of this approach is that several Cre lines may intersect with *Th* expression outside the midbrain, thereby labeling unwanted cells. Additionally for genes that have broader expression in DA neurons during development, this approach will label more cells than represented by the adult gene expression pattern. Strategy II exploits the INTRSECT viral system^[@R18]^, in which EYFP expression is activated uniquely in cells that express Cre and Flpo recombinases ([Fig. 2B](#F2){ref-type="fig"}). By virtue of targeted viral delivery, this strategy has the advantage of avoiding most other TH+ populations in the brain, as well as labeling adult neurons based on their ongoing, rather than developmental, expression of Cre and Flpo. Strategy III uses a Dat-tTA strain (tetracycline transactivator driven by the *Slc6a3 (Dat)* locus^[@R19]^), in conjunction with the intersectional reporter mouse Ai82^[@R17]^, in which EGFP expression is driven by tetracycline response element (TRE) in a Cre dependent manner ([Fig. 2C](#F2){ref-type="fig"}). The *Dat* locus has the advantage of being largely restricted to midbrain DA neurons^[@R16]^, barring few other neuronal populations (e.g. ventral premmamillary nucleus, PMv^[@R20]^). Together these complementary approaches form a powerful arsenal to target molecularly distinct DA neurons.

To validate Strategy I and to establish a pan-midbrain DA neuron projection map, we obtained Th--2A--Flpo;Dat--ires--Cre;Ai65 mice as well as control littermates. In mice with both Th--2A--Flpo and Dat--ires--Cre alleles, but not in controls, we observed strong fluorescence in midbrain DA neurons ([Fig. 2D](#F2){ref-type="fig"}). We also observed tdTomato expressing neurons in the arcuate nucleus of the hypothalamus (ARH), but none in the PMv. Since ARH DA neurons do not contribute to ascending DAergic pathways^[@R2]^, these experiments revealed ascending DA pathways in their entirety, which was neither possible using the *Th* nor *Dat* promoter alone. As depicted in [Figure 2G](#F2){ref-type="fig"}, tdTomato+ axonal fibers were observed in all known DA recipient regions. Thus, this intersectional genetic strategy provides a comprehensive picture of the projections of midbrain DA neurons. To establish the fidelity of Strategy II, we injected AAV---CreON,FlpON--EYFP virus in the SNc of mice with only the Th--2A--Flpo or Dat--ires--Cre allele, as well as mice with both alleles. In mice with both Flpo and Cre alleles, but not either one alone, we observed strong fluorescence in DA neurons ([Fig. 2E](#F2){ref-type="fig"}). Lastly, we validated Strategy III with Dat--ires--Cre;Dat-tTA;Ai82 mice, and observed robust fluorescence in DA cell bodies and axonal projections, but not in controls ([Fig. 2F](#F2){ref-type="fig"}). These experiments demonstrate that our three complementary intersectional strategies display fidelity, and therefore allow analysis of genetically-defined DA neuron projections.

Projections of genetically defined DA neuron subtypes to caudate putamen {#S5}
------------------------------------------------------------------------

Guided by single-cell based classification studies and other literature, we elected to use five Cre lines (*Ndnf*, *Sox6*, *Aldh1a1*, *Calb1* and *Vglut2*) in intersectional labeling experiments ([Table S1](#SD2){ref-type="supplementary-material"}), and elucidated three DA neuron subtypes in the SNc that displayed projections biased towards dorsolateral, ventromedial, and caudal CP.

### Ndnf+/Sox6+ DA neuron projections cover most areas of the dorsal striatum {#S6}

*Ndnf* is a gene encoding the neuron-derived neurotrophic factor which is expressed by at least two distinct SNc subtypes: the *Aldh1a1*+ subtype located in the ventral tier, and the *Aldh1a1*--subtype mainly located in the dorsal tier of the SNc but also in the dorsolateral VTA (a.k.a. parabrachial pigmented area; PBP)^[@R8],[@R9]^. Using Strategy I (i.e. Ndnf--dgCre;Th--2A--Flpo;Ai65 mice; see [methods](#S23){ref-type="sec"} for Cre activation), we observed tdTomato+ cells located in the SNc, dorsolateral VTA, and RR ([Table S1](#SD2){ref-type="supplementary-material"}). Co-labeling and quantification revealed that 98.5% (±0.5) expressed TH, 90.1% (±2.3) expressed SOX6, whereas only 1.3% (±0.7) expressed OTX2, consistent with previous single-cell gene expression studies^[@R8],[@R9]^. Some tdtomato+ neurons were present outside the midbrain, precluding projection analysis. Using Strategy III (Ndnf--dgCre;Dat--tTA;Ai82 mice) resulted in numerous DA neurons expressing EGFP that were located in the SNc, dorsolateral VTA and RR ([Fig. 3A,B](#F3){ref-type="fig"}). Similar to the results obtained with Strategy I, EGFP+ midbrain neurons were TH+ and the majority were SOX6+ ([Fig. 3B](#F3){ref-type="fig"}). The lack of labeled neurons outside the midbrain made this strategy amenable for projection analysis (see [Methods](#S23){ref-type="sec"} and [Fig. S4](#SD1){ref-type="supplementary-material"}). In these mice, TH+/EGFP+ axons follow the medial forebrain bundle (MFB), traverse the GPe, and innervate striatal targets. Within the dorsal striatum, fibers were observed at all rostrocaudal levels ([Fig. 3F](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}), were particularly dense in the ventral portion of the intermediate (CPi) and caudal caudate putamen (CPc; [Fig. 3H](#F3){ref-type="fig"}), but were significantly less dense in the tail of the caudate putamen (CPt; [Fig. 3F](#F3){ref-type="fig"} and [Fig. S5](#SD1){ref-type="supplementary-material"}).

We considered the possibility that the less dense innervation of the CPt was due to incomplete recombination by the inducible Ndnf--dgCre. The transcription factor *Sox6* has a similar expression pattern to *Ndnf*, being expressed in both *Aldh1a1*+ neurons in the ventral tier of the SNc, and in *Aldh1a1*--neurons in the dorsal tier of the SNc and the dorsolateral VTA^[@R8],[@R9],[@R21]^. To corroborate our findings using a second anchor gene, we generated a Sox6--FSF--Cre mouse line ([Fig. S6](#SD1){ref-type="supplementary-material"}). To validate the recombination specificity within the DAergic system, we crossed the Sox6-FSF-Cre with Th-2A-Flpo and the intersectional reporter RC::Frepe ([Table S1](#SD2){ref-type="supplementary-material"}). We found that 97.7% (±2.7) of EGFP+ neurons of the SNc were SOX6+, and that 82.7% (±1.9) of SOX6+/TH+ of the SNc were EGFP+. However, we could not use Strategy I for projection analysis since *Th* and *Sox6* gene expression intersected in cell populations outside the midbrain.

To reveal the projections, we therefore used Strategy II, and injected AAV--CreON,FlpON--EYFP in the SNc of Sox6--FSF--Cre;Th--2A-Flpo mice. We observed EYFP+ cells mainly in the SNc, and few in the dorsolateral VTA ([Fig. S6](#SD1){ref-type="supplementary-material"}). The vast majority of labeled neurons co-expressed TH and SOX6 ([Fig. S6](#SD1){ref-type="supplementary-material"}), but only a subset of these neurons express ALDH1A1 (not shown). The overall projection pattern displayed similarities to *Ndnf*, with fibers observed only in the striatum and not in other known DAergic targets ([Fig. S5](#SD1){ref-type="supplementary-material"}; [Table S1](#SD2){ref-type="supplementary-material"}). Overall, *Ndnf* and *Sox6* projections display important similarities (see [Fig. S5](#SD1){ref-type="supplementary-material"} for discussion regarding the subtle differences). Interestingly, the CPt had significantly less dense innervation in both Sox6-FSF-Cre and Ndnf--dgCre experiments ([Fig. 3F](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}). This suggests that the CPt receives a substantial innervation from a DA neuron subtype not defined by *Ndnf* and *Sox6* expression.

### Aldh1a1+ SNc DA neurons project principally to the dorsolateral caudate putamen {#S7}

The gene *Aldh1a1*, which encodes an enzyme of the aldehyde dehydrogenase 1 family, is expressed by two distinct DA subtypes: one located in the ventral tier of the SNc, and the other located largely in the IF and ventromedial VTA (a.k.a. paranigral (PN))^[@R8],[@R9]^. To genetically target *Aldh1a1*+ subtypes, we inserted the inducible recombinase CreER^T2^ at the start codon of the *Aldh1a1* gene ([Fig. S7](#SD1){ref-type="supplementary-material"}). In tamoxifen (TAM) treated Aldh1a1--CreER^T2^, Ai9 mice, 93.9% (±1.0) recombined cells were ALDH1A1+ ([Fig. S7](#SD1){ref-type="supplementary-material"}). Since this experiment resulted in recombination non-DA neurons (i.e. cortex, hippocampus, hypothalamus and cerebellum), we employed intersectional Strategy I. In the midbrain of Aldh1a1--CreER^T2^;Th--2A--Flpo;Ai65 mice, ALDH1A1+ DA neurons were reliably labeled with tdTomato, but very few neurons were labeled outside the midbrain (mainly found in the ARH). We observed tdTomato+ fibers in the CP, the ACB, and the LS, but no fibers were observed in the PFC ([Fig. S7](#SD1){ref-type="supplementary-material"}). In the CP, co-staining with μ opioid receptor (MOR) antibody revealed that some MOR+ patches did indeed display higher density of ALDH1A1+ projections ([Fig. S7](#SD1){ref-type="supplementary-material"}), similar to what was previously reported by ALDH1A1 and MOR co-immunolabeling^[@R22]^.

To distinguish between the two Aldh1a1 expressing DA subtypes, we injected DIO--AAV--EYFP into either the SNc or VTA of Aldh1a1--CreER^T2^ mice ([Fig. 3C](#F3){ref-type="fig"}; VTA injections will be discussed in the section on projections to the nucleus accumbens (ACB) and olfactory tubercle (OT)). In SNc injections, EYFP labeled cells were located in the ventral tier of the SNc, and co-expressed ALDH1A1, TH, SOX6, but not OTX2 ([Fig. 3C](#F3){ref-type="fig"}, S7), consistent with previous DA neuron subtype classification^[@R8],[@R9]^. In the representative injection displayed in [Fig. 3C](#F3){ref-type="fig"}, we observed EYFP+ fibers along the MFB, GPe, the subcallosal streak and the CP. Within the CP, fibers were observed in most rostrocaudal levels, but were notably sparse in CPt ([Fig. 3F](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}). Fibers were dense in the dorsolateral part of the CP and less dense ventrally, and were particularly concentrated in some striosomes in the CPi ([Fig. 3F, I](#F3){ref-type="fig"}). Overall, projections from ALDH1A1+ neurons of the SNc appear to be a subset of the *Sox6*+/*Ndnf*+ projections.

### Calbindin+ SNc DA neurons project to the ventromedial caudate putamen {#S8}

Within the *Sox6*+/*Ndnf*+ population, *Calb1* is enriched in *Aldh1a1--* neurons of the dorsal SNc^[@R8],[@R9]^. Applying Strategy III (Calb1*--*Cre; Dat*--*tTA;Ai82), we observed EGFP+ neurons located in the dorsal SNc, which includes the dorsolateral-most region (*pars lateralis* in some anatomical schemes; SNpl; [Fig. S8](#SD1){ref-type="supplementary-material"}), as well as in the VTA. Within the SNc, 69.9% (*±*5.9) of EGFP+ neurons were SOX6+. Most of the SOX6*--* cells were found in the SNpl, suggesting that Calb1+ might label at least two distinct nigral DA neuron subtypes. WIth regard to projections, dense fibers were observed in medial, but not lateral regions of CPr, a region also innervated by Aldh1a1+ fibers ([Fig. 3F](#F3){ref-type="fig"}). In the CPi and CPc, we observed projections that were mostly directed toward the ventromedial region with fewer fibers observed in the dorsolateral CP ([Fig. S8](#SD1){ref-type="supplementary-material"}). In contrast, we saw dense innervation throughout the CPt ([Fig. S8](#SD1){ref-type="supplementary-material"}).

To confirm the projection of nigral *Calb1*+ neurons, we used Strategy II and injected AAV*--*CreON,FlpON*--*EYFP virus in the SNc of Calb1*--*Cre;Th*--*2A*--*Flpo mice. Similar to the previous experiment ([Fig. S8](#SD1){ref-type="supplementary-material"}), the majority of EYFP+ neurons in the dorsal SNc expressed SOX6+, while cells labeled in the SNpl had low/absent SOX6 levels. Almost none of the EYFP+ cells co-expressed ALDH1A1 ([Fig. 3D](#F3){ref-type="fig"}). In the CP, we observed the same pattern of projections as obtained with Strategy III ([Fig. 3F,J](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}). Overall, two main points can be deduced from these data: first, the *Sox6*+/*Ndnf*+ DA neurons can be divided into at least two subtypes (*Aldh1a1*+ and *Calb1*+), the projections of each biased toward dorsolateral and ventromedial regions of the CP, respectively; and second, a *Calb1*+/*Sox6--*/Ndnf*--* population in the dorsolateral SNc (including the SNpl) could account for the innervation of the CPt.

### Vglut2+ DA neurons of the lateral SNc project to the tail of the striatum {#S9}

The gene encoding vesicular glutamate transporter (*Slc17a6*; *Vglut2)* has been reported mainly in DA neurons located in ventromedial VTA and IF^[@R5],[@R23]^. However, the Allen Brain Atlas ISH database depicts the presence of *Vglut2* mRNA in the dorsolateral region of the SNc. To demonstrate the existence of *Vglut2*+ DA neurons, we performed single-molecule RNA fluorescent *in situ* hybridization (smFISH) and observed several cells co-expressing *Vglut2* and *Th* mRNA mainly in the lateral SNc ([Fig. S9](#SD1){ref-type="supplementary-material"}), consistent with a recent publication^[@R24]^. *Vglut2* is known to be broadly expressed in DA neurons during development^[@R23]^, and unsurprisingly, when we applied Strategy I, we observed broad recombination in the SNc ([Table S1](#SD2){ref-type="supplementary-material"}). Thus, to determine the projections of *Vglut2*-expressing DA neurons in adult, we used Strategy II and injected AAV--CreON,FlpON--EYFP virus in the SNc of Vglut2--Cre;Th--2A--Flpo mice. We observed EYFP+ neurons in the dorsolateral part of the SNc ([Fig. 3A, E](#F3){ref-type="fig"}), but less in the more medial SNc or the RR. These EYFP+ DA neurons expressed TH, but only 7.6% ± 0.6 co-expressed ALDH1A1 ([Fig. 3E](#F3){ref-type="fig"}). The axonal projections were mostly absent from the CPr ([Fig. 3F](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}), although some areas with concentrated axons were found in the CPi ([Fig. 3F](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}). In the CPc, EYFP+ fibers were observed, partly overlapping with Aldh1a1 innervation in dorsolateral regions. In this experiment, the most densely innervated area was the CPt ([Fig. 3G](#F3){ref-type="fig"}). Based on these results, we posit that the *Vglut2*+ DA neurons of the dorsolateral SNc largely correspond to the *Calb1*+/*Sox6*--population identified earlier, a subtype that has not been definitively demarcated by previous classification studies^[@R8],[@R9]^. These neurons likely correspond to a population having a similar distribution in the SNc identified by retrograde virus tracing from the CPt^[@R25]^.

Projections of DA neuron subtypes to nucleus accumbens and olfactory tubercle {#S10}
-----------------------------------------------------------------------------

In this section, we will describe intersectional labeling experiments based on four Cre lines (*Cck*, *Aldh1a1*, *Vglut2*, and *Sox6*; see [Table S1](#SD2){ref-type="supplementary-material"}) and will discuss their projections to the ACB core, shell, and OT regions.

### Cck+ DA neurons project to all regions of the ACB and OT {#S11}

Applying Strategy I with Cck--Cre (Cck--Cre;Th--2A--Flpo;Ai65), we observed recombined cells across the VTA, the IF, and the CLi, as well as some neurons located in the dorsal SNc. In this experiment, we observed tdTomato+ fibers in all regions of the ACB and OT, although labeled neurons outside the midbrain precluded projection analysis ([Table S1](#SD2){ref-type="supplementary-material"}). Therefore, we used Strategy II and injected the intersectional virus into the VTA of Cck--Cre;Th--2A--Flpo mice ([Fig. 4A--B](#F4){ref-type="fig"} and [S10](#SD1){ref-type="supplementary-material"}). In such experiments, the starter population had a similar distribution as in Strategy I ([Fig. 4A--B](#F4){ref-type="fig"}). Some EYFP+ neurons were SOX6+, whereas other were OTX2+, indicating that at least two subtypes are labeled by this Cre line ([Fig. 4B](#F4){ref-type="fig"}). Regarding projections, we observed fibers in the core and shell (medial, ventral and lateral) regions of the ACB, as well as throughout the OT ([Fig. 4F,J](#F4){ref-type="fig"} and [S10](#SD1){ref-type="supplementary-material"}). Within the dorsal striatum, fibers were also observed in the medial part of the CPr and CPi ([Fig. S4](#SD1){ref-type="supplementary-material"}) in line with previous results demonstrating a VTA projection toward the medial CP^[@R26]^. Overall, *Cck* likely defines multiple populations demonstrating the necessity to employ more specific Cre drivers to label DA subtypes within the VTA.

### Sox6+ neurons in the dorsolateral VTA innervate the ACB core and lateral shell {#S12}

To investigate the contribution of VTA *Sox6*+ neurons, we used Strategy II and injected AAV--CreON,FlpON--EYFP in the VTA of Sox6--FSF--Cre;Th--2A--Flpo mice. Recombined cells were mostly located in the dorsolateral portion of the VTA (PBP region), although some EYFP+ neurons were observed in the medial SNc as well ([Fig. 4A, C](#F4){ref-type="fig"}). EYFP+ positive cells were SOX6+, but OTX2-- ([Fig. 4C](#F4){ref-type="fig"}). In the ACB, EYFP+ fibers were most dense in the ACB core and lateral shell ([Fig. 4F](#F4){ref-type="fig"} and [S10](#SD1){ref-type="supplementary-material"}). Fewer fibers were found in the OT and the ACB medial shell ([Fig. 4F--G](#F4){ref-type="fig"}), but interestingly, two small areas located in the ventral shell also receive *Sox6*+ innervation ([Fig. 4G](#F4){ref-type="fig"}; arrows) that may correspond to the D2R-expression poor areas described by Gangarossa et al.^[@R27]^. Similar to SNc targeted injections in Sox6--Cre;Th--2A--Flpo mice, here we also observed projections to the medial CPr and CPi. No labeled fibers were found outside the striatum, suggesting that *Sox6* might define DA neurons that predominantly innervate striatal targets.

### Vglut2+ and Aldh1a1+ DA neurons of the VTA projects to ACB medial shell and OT {#S13}

To investigate the projections of *Vglut2*-expressing DA neurons of the ventromedial VTA^[@R5],[@R23]^, we employed Strategy II. Injections into the VTA resulted in EYFP+/TH+ cells largely in the PN region, IF and CLi, but also often resulted in EYFP+/TH-- cells in the RLi ([Fig. 4A, D](#F4){ref-type="fig"}). Immunolabeling revealed that few, if any, EYFP+/TH+ neurons were SOX6+, but the majority were OTX2+ ([Fig. 4D](#F4){ref-type="fig"}). A subset of EYFP+/OTX2+ cells were ALDH1A1+ (not shown). Within the striatum, we found EYFP+ fibers most densely in the ACB medial shell, in a somewhat complementary manner to *Sox6* projections ([Fig. 4F, I](#F4){ref-type="fig"} and [S10](#SD1){ref-type="supplementary-material"}). In the OT, we found EYFP+ fibers in discrete, dense column-like structures ([Fig. 4I](#F4){ref-type="fig"} and [S10](#SD1){ref-type="supplementary-material"}), in contrast to the *Cck* labeling experiments in which widespread OT labeling was observed. Similar results were obtained with Adcyap1--Cre ([Table S1](#SD2){ref-type="supplementary-material"}).

We next assessed the projections to the ACB from *Aldh1a1*+ DA neurons of the VTA, applying Strategy I (Aldh1a1--CreER^T2^;Th--2A--Flpo;Ai65). Focusing on the ACB, we observed a strong innervation of the ACB medial shell and OT, and significantly less fibers innervating the core and lateral shell ([Fig. S7](#SD1){ref-type="supplementary-material"}). To exclude the contribution of *Aldh1a1* SNc neurons, we next injected a small volume of virus into the VTA of Aldh1a1--CreER^T2^ mice resulting in EYFP+ cells in the VTA, IF, and CLI regions ([Fig. 4A, E](#F4){ref-type="fig"}). Of the EYFP+ cells 95.7% (±2.3) were OTX2+, and only 4.2% (±1.9) expressed SOX6 ([Fig. 4E](#F4){ref-type="fig"} and [S7](#SD1){ref-type="supplementary-material"}). EYFP+ fibers were observed in the ACB medial shell and in the OT ([Fig. 4F,H](#F4){ref-type="fig"} and [S10](#SD1){ref-type="supplementary-material"}). Taken together with Vglut2--Cre experiments, ALDH1A1+ neurons in the VTA are a subset of the *Vglut2*+ population, and accordingly, ALDH1A1+ projections in the medial shell are a subset of the *Vglut2* projections.

Projections of genetically defined DA neurons to the amygdala {#S14}
-------------------------------------------------------------

In Dat--ires--Cre;Th--2AvFlpo;Ai65 mouse brains, labeled fibers were observed in the central (CEA), intercalated nuclei (IA), the basolateral (BLA), and the posterior nuclei ([Fig. 5A](#F5){ref-type="fig"}). Sparse tdTomato+ fibers were also observed in the lateral nucleus (LA), medial nucleus (MEA) and amygdalar cortical areas. To investigate if these amygdalar nuclei received a differential innervation for DA neuron subtypes, we used three Cre drivers (*Vip*, *Cck*, *Vglut2*; [Table S1](#SD2){ref-type="supplementary-material"}).

### Vip+ DA neurons project to the lateral part of the central amygdala {#S15}

In Vip--Cre;Th--2A--Flpo;Ai65 brain sections, we found tdTomato+ neurons in the CLi and PAG/DR ([Fig. 5B--C](#F5){ref-type="fig"}), that co-localized with TH, but not with SOX6 or OTX2 ([Fig. S11](#SD1){ref-type="supplementary-material"}). Similar results were observed using Strategy III (Vip--Cre;Dat--tTA;Ai82; [Fig. S11](#SD1){ref-type="supplementary-material"}), although slightly fewer neurons were labeled. 67.0% (± 9.0) of EGFP+ neurons expressed TH. With both strategies, labeled fibers were found in the lateral part of the CEA, although some fibers were also observed in the medial part of the CEA ([Fig. 5F,H](#F5){ref-type="fig"}; [Fig. S11](#SD1){ref-type="supplementary-material"}). Strikingly, no fibers were present in the BLA or other nuclei of the amygdala.

### Vglut2+ DA neurons of the SNc innervate the capsular part of the central amygdala {#S16}

The *Vglut2*+ DA neurons in the lateral SNc also contribute to the innervation of the amygdala ([Fig. 5B, D](#F5){ref-type="fig"}), in addition to the CPt innervation already described. These cells send projections to the lateral part of the capsular division of the CEA (CEAcl), and are mostly excluded from other divisions of the CEA ([Fig. 5F, I](#F5){ref-type="fig"}). We also observed sparse fibers reaching the ventral most LA nucleus and the posterior nucleus of the amygdala (PA; [Fig. 5F](#F5){ref-type="fig"}).

### Cck+/Vglut2+ DA neurons of the VTA innervate the basolateral amygdala {#S17}

Labeling of *Cck*+ DA neurons using Strategy I resulted in tdTomato+ fibers in the medial and lateral part of the CEA (CEAm and CEAl), in the anterior and posterior BLA, as well as in the intercalated nuclei located in the external capsule (not shown). Using Strategy II, injections in the VTA resulted in EYFP+ fibers in a similar fashion, except for the CEAl ([Fig. 5B, E, F, G](#F5){ref-type="fig"}). This difference in labeling between Strategy I and II could be explained by limited dispersion of viral particles, as these may not have reached *Cck*+ DA neurons that project to the CEAl. The *Cck*+ neurons that project to the CEAl are likely to be located in the DR/PAG and to encompass the *Vip*+ neurons. Similar to *Cck*, labeling *Vglut2+* VTA neurons using Strategy II ([Fig. 4D](#F4){ref-type="fig"}) resulted in a more restricted labeling within the amygdala. In this experiment, we principally observed a sparse innervation of the BLA ([Table S1](#SD2){ref-type="supplementary-material"}). Overall, the amygdala receives a varied innervation from genetically defined DA neurons located in the DR/PAG, SNc, and VTA.

Projections of genetically defined DA neurons to other regions {#S18}
--------------------------------------------------------------

### DA neuron subtype innervation of the prefrontal and entorhinal cortices {#S19}

Using the Dat--ires--Cre driver in Strategy I (Dat--ires--Cre;Thv2A--Flpo;Ai65), we observed several tdTomato+ fibers in the infralimbic and prelimbic cortical areas ([Fig. 6A](#F6){ref-type="fig"}). We also observed labeled fibers in the ENT and these were more concentrated in certain regions ([Fig. 6D](#F6){ref-type="fig"}), reminiscent of the DAergic islands observed in Mingote et al^[@R28]^. To investigate which DA subtype innervates the PFC and ENT, we examined all previous experiments for the presence of fibers in these cortical areas. We observed EYFP+ fibers in the PFC and ENT using Strategy II with viral injectons in the VTA, with Cck--Cre ([Fig. 6E, H](#F6){ref-type="fig"}), and Vglut2--Cre ([Fig. 6I, L](#F6){ref-type="fig"}). In the PFC, axons were mostly found in the deep layers of the infralimbic and prelimbic cortices, but were more sparse when compared to Dat--ires--Cre;Th--2A--Flpo;Ai65 samples. Taken together, these data suggest that the mesocortical DA projections are derived, at least in part, from *Vglut2*+/*Cck*+ DA neurons that are located in the ventromedial VTA.

### Aldh1a1+ DA neurons of the VTA project to the lateral septum {#S20}

We observed strong innervation of the lateral septum (LS) in the Dat--ires--Cre;Th--2A--Flpo;Ai65 mouse ([Fig. 6B](#F6){ref-type="fig"}). Analyzing all previous experiments, we observed labeled fibers in the LS using Strategy II only in Cck--Cre ([Fig. 6F](#F6){ref-type="fig"}), Vglut2--Cre ([Fig. 6J](#F6){ref-type="fig"}) and Aldh1a1--CreER^T2^ ([Fig. S7](#SD1){ref-type="supplementary-material"}) experiments. Altogether, our findings suggest that at least two types of *Vglut2*+/Cck+ DA neurons populate the VTA: *Aldh1a1*+ DA neurons that project to the ACB, OT and LS; and *Aldh1a1*-- neurons that might contribute to these projections but also project to the PFC and ENT.

### Vip+ and Cck+ DA neurons project to the bed nucleus of the stria terminalis {#S21}

The BST receives an important innervation from midbrain DA neurons ([Fig. 6C](#F6){ref-type="fig"}) and we observed consistent BST innervation with two Cre lines: Vip--Cre and Cck--Cre. In the case of Vip-Cre, using Strategy I, we observed dense tdTomato+ fibers in the oval and juxtacapsular nuclei of the BST, with sparse fibers also found in the anterolateral nucleus ([Fig. 6K](#F6){ref-type="fig"}). In the case of Cck--Cre, using Strategy II, we observed EYFP+ fibers in the BST, mostly in the anterolateral nucleus, although sparse fibers were also observed in the oval and juxtacapsular nuclei as well ([Fig. 6G](#F6){ref-type="fig"}). As observed in the CEA, the *Cck*+ VTA population labeled with Strategy II appears to project to the BST in a complementary manner to *Vip*+ PAG/DR DA neurons.

Discussion {#S22}
==========

As a step towards understanding the neuroanatomical correlates of DA neuron diversity, we developed intersectional genetic strategies to target DA neuron subtypes and demonstrated that they possess distinct but partly overlapping projection patterns, even within a given target region ([Fig. 7](#F7){ref-type="fig"}; [Table S1](#SD2){ref-type="supplementary-material"}, [Table S2](#SD2){ref-type="supplementary-material"}). We demonstrated three distinct projection patterns arising from molecularly-defined DA neurons of the SNc and RR that segregate along the rostrocaudal, mediolateral and dorsoventral axes of the CP ([Fig. 7](#F7){ref-type="fig"}). A first distinct projection pattern originates from *Aldh1a1*+/Sox6+/Ndnf+ neurons, which correspond to DA-1A^[@R8]^ or DA-SNC^[@R9]^. These neurons send fibers mainly to the CPr, CPi and CPc, which are particularly dense in the dorsolateral region and in some striosomes. Interestingly, this population projects predominantly to locomotor areas of the striatum^[@R29]--[@R31]^, and was shown to be particularly vulnerable in a mouse model of PD^[@R8]^. A second projection arises from the *Calb1*+/*Sox6*+/*Aldh1a1*-- neurons of the SNc, which are located in the dorsal SNc as well as in the PBP (DA-1B^[@R8]^ or VTA1^[@R9]^). These neurons densely innervate the medial CPr, partly overlapping with the *Aldh1a1*+ projection, as well as the ventromedial regions of the CPi and CPc in a somewhat complementary manner to *Aldh1a1*+. A key finding in this study is the genetic targeting of a *Vglut2*+/*Calb1*+/Sox6-- DA neuron subtype located principally in the lateral SNc that sends dense projections to the CPt. SNc neurons projecting to the CPt have recently been identified as a separate class, based on unique inputs^[@R25]^. Imaging studies have shown CPt projecting DA neurons are strongly activated by novel cues and might encode general salience rather than error prediction, unlike other SNc DA neurons^[@R32]^. Taken together with our findings, this points to the possibility that this *Vglut2*+ DA neuron population is embedded in a unique circuit with distinct functional properties. Overall, we have demonstrated that SNc DA subtypes have topographically biased projections along the rostrocaudal, mediolateral and dorsoventral axes of the CP, possibly aligning with previously described functional subdivisions^[@R32]--[@R36]^. Consistent with this notion, recent studies have pointed to the fact that the striatum is also segregated in terms of its corticostriatal inputs^[@R29],[@R30]^, as well as in terms of distributions of D1 and D2 expressing medium-spiny neurons^[@R37]^.

We uncovered distinct projection patterns arising from genetically defined DA neuron populations in the VTA and other medial clusters (IF, CLi, and DR/PAG). An *Aldh1a1*+ DA neuron subtype (DA-2B^[@R8]^ or DA-VTA2^[@R9]^) sends axonal projections principally to the ACB medial shell, OT and LS. *Aldh1a1*+ cells in the VTA were found also to express *Otx2*^[@R38]^, *NeuroD6*^[@R9],[@R39]^, *Adcyap1*^[@R8],[@R9]^, *Lpl*^[@R8],[@R9]^, and *Vglut2*^[@R8]^. Consistent with this latter finding, optogenetic stimulation of DA fibers in the ACB shell and OT elicits strong glutamatergic currents^[@R28],[@R40]^, and VGLUT2+/TH+ fibers are found in the ACB shell and OT^[@R41]^. Interestingly, rats learn to self-administer amphetamine, cocaine or DA agonists directly into the medial shell and OT, but do not learn self-administration into the lateral shell or ACB core, pointing to the relevance of this genetically defined circuit for drug addiction^[@R6]^. A second deduced DAergic pathway, arising from *Vglut2*+/*Aldh1a1*-- neurons of the VTA, also sends projections to the ENT and PFC. DA projections to the ENT and PFC have also been shown to co-release glutamate^[@R28],[@R42]^, and do not arise from the same neurons that project to the ACB^[@R43]^. A third DA pathway, defined by *Vip*, sends projections to the CEA and BST. This population is likely part of the DAergic pathway arising from the DR/PAG, which has been shown to be involved in social behavior^[@R44]^ and wakefulness^[@R15]^. A fourth DAergic pathway arises from a *Calb1*+/*Sox6*+/*Ndnf*+ VTA population located in the PBP region and dorsal SNc, and is mainly directed toward the core and lateral shell of the ACB and the medial CP as discussed above, in a pattern complementary to VTA *Vglut2*+ projections. The *Calb1*+/*Sox6*+/*Ndnf*+ projections are consistent with previous analyses showing that lateral shell projecting DA neurons are distinct from those projecting to the medial shell or PFC^[@R43],[@R45],[@R46]^. These cells are distinct from the other VTA DA neurons as they do not express *Otx2*, *Adcyap1* or *Vglut2*, and seem to correspond to the population DA-1B^[@R8]^ and DA-VTA1^[@R9]^.

In summary, we have harnessed the power of intersectional genetic paradigms to access several molecularly defined DA neuron subtypes, and have provided an initial framework to dissect DA neuron diversity. Although this framework is likely to be refined in future, we envision that the tools generated here, in conjunction with an improved arsenal of intersectional reporter mice^[@R13],[@R17]^ and viruses^[@R18]^, for neuron ablation^[@R47]^, excitation^[@R48]^ or inhibition^[@R49],[@R50]^, will provide a starting point for functional interrogation of DA neuron subtypes in normal and diseased states.

Materials and Methods {#S23}
=====================

Generation of transgenic mice {#S24}
-----------------------------

### Th--2A--Flpo {#S25}

To generate Th--2A--Flpo mice, we obtained KOMP targeted ES cell clone Th_C09^[@R51]^ from the KOMP repository Mutant Mouse Reginal Resource Center (MMRRC). This clone has been genetically modified such that the Engrailed splice acceptor (SA) followed by ires--lacZ cassettes have been inserted in the intron following exon 6 of the *Th* gene. We used dual Recombinase Mediated Cassette Exchange (dRMCE)^[@R52]^ to reengineer this *LacZ* allele into the Th--2A--Flpo allele. To achieve this we generated a targeting vector that included exons 7 to 13 of *Th* coding sequence, the autocalytic peptide P2A, Flpo, WPRE sequence, a bovine growth hormone polyadenylation signal (bGH pA) followed by puromycin selection cassette flanked by rox sites. Since the two coding sequences are separated by virtue of a ribosome skipping event that occurs at the glycyl-prolyl peptide bond at the C-terminus of the 2A peptide (effectively, an autocatalytic "cleavage")^[@R53]^, by design, any cell that is translating TH protein will also synthesize Flpo. The targeting construct was electroporated in KOMP ES cells in combination with the plasmid pDIRE (Addgene: \#26745), which induces high level of iCre and Flpo expression, and we selected for puromycin (the replacement selection cassette). We screened 62 clones by PCR using multitude combinations of primers, out of which 63% were positive for the presence of Flpo. Of these clones 26% had lost the *lacZ* and neomycin suggesting a correct integration at the *Th* locus and a successful RMCE. Locus targeting was confirmed by sequencing of PCR products spanning the entire region and the junctions. These reengineered ES clones were injected into blastocyst by Northwestern University Transgenic and Targeted Mutagenesis Laboratory (TTML). The puromycin selection cassette was later removed by crossing Th--2A--Flpo mice to CAG--Dre transgenic mice (MMRRC: 032246-UCD)^[@R54]^.

### Aldh1a1--CreER^T2^ {#S26}

Since *Aldh1a1* is express in DA neuron progenitors^[@R55]^, we opted to generate an inducible Cre. The short (2 Kb) and long arm (4 Kb) of the targeting vector were PCR cloned from RP23--129n10 BAC clone into pCRII--topo. A CreER^T2^ fragment from pCreER^T2\ [@R56]^, a WPRE fragment (pLemir; Open Biosystems), bGH pA were subcloned into pBS-SK+. The short arm and long arm were cloned upstream and downstream respectively of this construct. Site mutagenesis was used to align CreER^T2^ open reading frame with the endogenous ATG locus of *Aldh1a1* gene^[@R57]^. We then added a PGK--Neo cassette flanked with FRT sites (pK-11; gift from Dr. Meyers^[@R58]^) after the WPRE and bGH pA. In addition, we added a DTA selection cassette (pRosaPAm1) downstream of long homology arm. DNA was linearized with SwaI and both constructs were electroporated in PRXB6/N ES cells by Northwestern University TTML. Correctly targeted clones were identified with long range PCR and validated by sequencing.

### Sox6--FSF--Cre {#S27}

The 2 Kb short and 6 Kb long arms as well as a 200bp fragment containing the ATG (exon 3) were obtained by PCR from RP24--83n9 BAC clone. The 5637bp FRT--STOP--Puro--FRT cassette from FSF--TOPO (Addgene \#22774) vector was cloned in between the short arm and the 200bp fragment, in the intronic region between Sox6 exon 2 and 3. A NLS--CrevpolyA cassette was cloned by aligning the ORF with the endogenous ATG and preceding 6Kb long arm. A DTA--polyA cassette was cloned at the 3' end of the long arm for negative selection. The final construct (20,974bp) was linearized with PacI and electroporated in PRXB6/N ES cells by Northwestern University TTML. Correctly targeted clones were identified with long range PCR and sequenced.

Mice breeding and husbandry {#S28}
---------------------------

Mice were maintained and euthanized according to the protocols approved by the Northwestern University Animal Care and Use Committee. Animals were provided food and water *ad libitum* and were maintained on a regular 14h:10h day/night cycle at no more than five adult animals per cage. Animals were maintained on the C57Bl/6 background by backcrossing to females (Charles River; Strain 574). Both males and females were used in this study, as there is no evidence in the literature of differential DAergic projection between gender. The mice used in this study were obtained in part from the Jackson Laboratory: Ai65 (stock \#021875), Ai82 (stock \#023532), Dat--ires--Cre (stock \#006660), Cck--ires--Cre (stock \#012706), Vip--ires--Cre (stock \#010908), and Vglut2--ires--Cre (stock \#016963). Others were generously provided by the Allen Institute for Brain Science (Calb1--ires--Cre and Ndnf--ires--dgCre^[@R59]^), Dr. Susan Dymecki (RC::FA and RC::Frepe^[@R60]^), and Dr. Xiaoxi Zhuang (Dat--tTA^[@R61]^). All experimental animals were heterozygous for the recombinase or tTA transgenes. For induction of Ndnf--dgCre 4--8 week old mice were injected by with Trimethoprim in a procedure modified from Sando et al.^[@R62]^ as described below. In short, 15mg of Trimethoprim lactate (Sigma; T0667) was dissolved in 500μL H~2~O, mixed with 500μL of 2X PBS. The mice were injected at a concentration of 0.170μg/g, for three injections 48h apart. To induce Cre recombination in Aldh1a1--CreER^T2^ mice, we performed five daily injections (1mg/40g) of tamoxifen (Sigma; T5648) diluted in corn oil (Sigma; C8264) to a final concentration of 10mg/mL, in 4--8 week old Aldh1a1--CreER^T2^ mice. We waited at least 3 weeks after the last tamoxifen or trimethoprim injection before proceeding with perfusion for adequate reporter expression.

Stereotaxic surgeries {#S29}
---------------------

Mice were anesthetized with 3% isoflurane and placed onto a stereotaxic apparatus, kept under anesthesia with 2% isoflurane. Mice were then given a subcutaneous injection of Buprenex (0.1mg/kg). The top of the head was shaved and scrubbed with Betadine followed by 70% Ethanol. An incision was made to reveal the skull. Using bregma as a reference point, the stereotaxic coordinates of the VTA (RC: −3.4mm, ML:−0.4mm; DV: −4.2mm) or the SNc (RC:−3.1mm; ML: −1.5mm: DV: −4.2) were used to obtain the location of where a small hole was drilled in the skull. The needle of a Hamilton Neuros Syringe filled with CreON,FlpON--EYFP INTRSECT viruses (AAVdj--hSyn--Con/Fon--EYFP, titer 1.1×10^13^vg/ml; AAVdj--nEF--Con/Fon--EYFP, titer 2.4×10^12^vg/ml; as previously generated^[@R18]^) was slowly lowered into the injection site and held for five minutes. Injection of 0.1 to 0.5μL of virus was made over five minutes. The needle was removed five minutes after the end of the injection. The skull was washed with sterile PBS and the wound was closed using staples. Mice were removed from the stereotaxic apparatus, and a subcutaneous injection of Rimadyl (5.0 mg/kg) was given. Mice were perfused 4 to 6 weeks after viral injections.

Immunofluorescence {#S30}
------------------

Adults mice (more than 8 weeks of age) were perfused with cold 4% PFA in PBS, the brains were dissected and fixed overnight in the same solution, cryoprotected in 30% sucrose PBS solution, sectioned at 25μm using a freezing microtome, and stored in −20°C in cryoprotectant solution. For immunofluorescence on free-floating sections, we initially rinsed in PBS, blocked in 5% donkey serum, 0.3% Triton X-100 in PBS, and incubated overnight at 4°C with primary antibodies diluted in blocking solution: rabbit anti-ALDH1A1 (Cat\# ab23375; Abcam; 1:200)^[@R8]^, goat anti-βgal (Cat\# 4600--1409; Biogenesis; 1:1500)^[@R20]^, rabbit anti-βgal (Cat\# 55976; Cappel; 1:1500)^[@R63]^, goat anti-FOXA2 (Cat\# sc-6554; Santa Cruz; 1:50)^[@R64]^, chicken anti-GFP (Cat\# ab13970; abcam; 1:1,500)^[@R20]^, rabbit anti-NURR1 (Cat\# sc-990; Santa Cruz; 1:500)^[@R8]^, goat anti-OTX2 (Cat\# GT15095; Neuromics; 1:200)^[@R8]^, rabbit anti-SOX6 (Cat\# ab30455; Abcam; 1:500)^[@R8]^, rabbit anti-TH (Cat\# P40101; Pel-Freez; 1:500)^[@R20]^, sheep anti-TH (Cat\# P60101--0; Pel-Freez; 1:500)^[@R8]^, and rabbit anti-VIP (Cat\# ab43841; Abcam; 1:500)^[@R8]^. Sections were rinsed in PBS+0.05% Tween20 solution and incubated with secondary antibodies generated in donkey and conjugated with appropriate fluorophores (Alexa488, Alexa555, Alexa647; Molecular Probes) diluted 1:250 in blocking solution and counterstained with DAPI (Sigma), rinsed in PBS+0.05% Tween20, and finally coverslipped with Gelvatol.

Image acquisition and processing {#S31}
--------------------------------

Epifluorescence images were acquired on a Leica DM5000 and Olympus Slide Scanner VS120, whereas confocal images were acquired on Nikon A1 confocal (Northwestern Cell Imaging Facility; NCI-CCSG-P30-CA060553). For the dorsal striatum, we imaged level 41 (CPr; +1.345mm from bregma), level 53 (CPi; +0.145mm from bregma), level 61 (CPc; −0.655mm from bregma), and finally level 69 (−1.455mm from bregma; aka the tail of the striatum CPt) of the Allen Reference Atlas (ARA) based on a previously published cortical-striatal projection analysis^[@R29]^. For the nucleus accumbens, we imaged level 41 (ACBr; +1.345mm from bregma), level 44 (ACBi; 1.045mm from bregma), and level 47 (ACBc; 0.745mm from bregma) of the ARA. For the amygdala, we imaged level 66 (−1.155mm from bregma), level 70 (−1.555mm from bregma), level 73 (−1.855mm from bregma), and level 77 (−2.255mm from bregma). To generate the axonal traces for figure depiction, the images were converted to single channel and inverted, and thresholded in Fiji. The images were then vectorized in Adobe Illustrator (CC2018) using the Image trace function and superposed to Allen Reference Atlas. Images brightness and contrast was adjusted in Fiji and figures were assembled in Adobe Illustrator (CC2018).

Quantitative analysis {#S32}
---------------------

To quantify starter populations expressing the fluorescent protein, and assess the colocalization with TH and subtype specific markers, we imaged 10X images on a Leica DM5000 microscope. For every Cre line quantified, we counted at least 6 images representative of the rostro-caudal distribution of DA neurons, in at least 3 different brains.

Statistic and reproducibility {#S33}
-----------------------------

The results are reported as average per brain (± standard error of the mean). No statistical analysis was performed in this study. No data point was excluded. No statistical methods were used to pre-determine sample sizes, but our sample sizes are similar to those reported in previous publication^[@R8],[@R20]^. The number of animal used in each experiment is listed in [Table S1](#SD2){ref-type="supplementary-material"}. For each experiment, mice were arbitrarily assigned for stereotaxic surgery, or were processed for imaging accordingly to the available genotype. Data collection and analysis were not performed blind to the conditions of the experiments.

Reporting Summary {#S34}
-----------------

Further information on experimental design and analysis is available in the Life Sciences Research Reporting Summary linked to this article.

Reagent and data availability {#S35}
-----------------------------

All newly generated mouse lines will be made available upon request. The original axonal tracing data that support the findings depicted in Figures [3](#F3){ref-type="fig"} to [5](#F5){ref-type="fig"} are available online ([labs.feinberg.northwestern.edu/awatramani/data/poulin-et-al-2018.html](http://labs.feinberg.northwestern.edu/awatramani/research/research-name.html)). Additional data or reagents are available from the corresponding author upon reasonable request.

Supplementary Material {#SM1}
======================
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![Generation and validation of Th--2A--Flpo\
(A) We used dual Recombinase Mediated Cassette Exchange (dRMCE) to reengineer a previously generated Th--LacZ allele in which lacZ expression is driven by the tyrosine hydroxylase (*Th*) transcription by virtue of a splice acceptor (SA) located in the intron between the 6^th^ and 7^th^ exon. We converted this allele and replaced lacZ by exons 7 to 13 of the *Th* coding sequence, followed by the P2A peptide, and the recombinase Flpo.(B) Simplified schematic of Th--2A--Flpo crossed to reporter mouse RC::FA, designed to activate nlacZ expression in midbrain DA neuron clusters resulting in nuclear βgal expression (black triangles = FRT sites). (C) In Th--2A--Flpo; RC::FA midbrain, the large majority of TH+ neurons (green) of the substantia nigra *pars compacta* (SNc; 99.9% (±0.1)), the ventral tegmental area (VTA; 100.0%), interfascicular nucleus (IF; 100.0%), retrorubral area (RR; 100.0%), caudal linear nucleus (CLi; 100.0%), and periaqueductal gray/dorsal raphe regions (PAG/DR; 99.6% (±0.2); not shown) are βgal+ (red). We observed some βgal+ cells are TH-- (examples are indicated with arrowhead), particularly in the rostral linear nucleus (RLi), interpeduncular nucIeus (IPN), and CLi. The fact that TH protein synthesis is required for Flpo production, because of effective P2A "autocatalytic" activity, suggests that these recombined cells produced TH protein, at least at some point during their developmental history. However, the majority of βgal+ cells also expressed TH in all DA neuron clusters: SNc (98.9% ±0.3), VTA (97.5% ±1.2), IF (85.8% ±5.8), CLi (88.1% ±2.4), RR (97.6% ±1.5) and the PAG/DR (68.4% ±5.1; not shown). n = 3.. PN = paranigral region, PBP = parabrachial pigmented area. Scale bar = 100 μm](nihms-977239-f0001){#F1}

![Three intersectional strategies to genetically target dopamine neuron subtypes\
(A) A first strategy is to use subtype-specific Cre drivers in combination with Th--2A--Flpo and the intersectional reporter mouse Ai65 (or equivalent), which results in tdTomato expression only in cells expressing both Cre and Flpo recombinases. (B) A second strategy is to use subtype-specific Cre drivers, in combination with both Th--2AvFlpo and the INTRSECT viral system. This virus leads to EYFP expression in neurons expressing both Cre and Flpo recombinases. A simplified schematic of the INTRSECT virus is shown. (C) A third strategy is to use Cre drivers in conjunction with Dat--tTA and Ai82 intersectional reporter mice. In this reporter, EGFP expression is driven by Dat--tTA, following Cre recombination. (D) Validating Strategy I, we only detected tdTomato expression in midbrain DA neurons in mice with both Dat--ires--Cre and Th--2A--Flpo alleles, whereas no tdTomato was observed in the absence of Dat--ires--Cre or Th--2A--Flpo. (E) Validating strategy II, we observed strong EYFP fluorescence after viral injection of hSyn--CreON,FlpON--EYFP in mice with both Datvires--Cre and Th--2A--Flpo alleles, whereas no EYFP was observed in the absence of Dat--ires--Cre or Th--2A--Flpo. (F) For Strategy III, we observed EGFP labeling in Ai82+ mice having both Dat--ires--Cre and Dat--tTA alleles, whereas no fluorescence was observed in controls. (G) Using Dat--ires--Cre;Th--2A--Flpo;Ai65 mice to provide a comprehensive picture midbrain DA neuron projections, we observed tdTomato labeled fibers in the caudate putamen (CP), nucleus accumbens (ACB), olfactory tubercule (OT), prefrontal cortex (PFC), lateral septum (LS), bed nucleus of the stria terminalis (BST), basolateral amygdala (BLA), and external globus pallidus (GPe). We also observed very sparse tdTomato+ fibers in the lateral habenula, motor cortical areas, and rostral pontine regions (not shown). Grey triangles = loxP sites, grey triangle outline = lox2722, grey striped triangle = loxN, black triangles = FRT sites, black triangle outline = F3 sites, black striped triangle = F5. See [Table S1](#SD2){ref-type="supplementary-material"} for number of animal replicates for each experiment. Scale bars = 400 μm](nihms-977239-f0002){#F2}

![Dopamine neuron subtype projections to the caudate putamen\
(A) Distribution of DA neuron subtypes used in the intersectional genetic experiments to trace projections in the caudate putamen (CP; each dot = 3 neurons; yellow = *Ndnf* experiment shown in B, red = *Aldh1a1* experiment shown in C, green = *Calb1* experiment shown in D, blue = *Vglut2* experiment shown in E). (B) In Ndnf--dgCre;Dat--tTA;Ai82 mice, EGFP+ cell bodies are located throughout the SNc, the dorsolateral VTA and RR. The vast majority of these cells express TH and SOX6 (arrowheads). (C) Example of a Aldh1a1--CreER^**T**2^ brain injected in the SNc with AAV--CreON--EYFP virus. EYFP cells were positive for TH and ALDH1A1. (D) Injection of Calb1--Cre;Th--2A--Flpo mouse with a AAV--CreON,FlpON--EYFP virus in the SNc. Most EYFP+ cells did not express ALDH1A1. (E) Injection of a AAV--CreON,FlpON--EYFP virus in the SNc of Vglut2--Cre;Th--2A--Flpo mouse yields labeled neurons in the dorsolateral part of the SNc (corresponding in part to the *pars lateralis*). A small fraction of these neurons is ALDH1A1+ (arrowhead). (F) Distinctive areas of the dorsal striatum are innervated in the experiments described above, shown at different rostrocaudal levels (CPr = rostral, CPi = intermediate, CPc = caudal, CPt = tail). (G-J) Representative images from these experiments (See [Table S1](#SD2){ref-type="supplementary-material"} for number of animal replicates for each experiment). Scale bars: B-E low mag. = 200 μm, high mag. = 40 μm; G-J =200 μm.](nihms-977239-f0003){#F3}

![Dopamine neuron subtype projections to the nucleus accumbens and olfactory tubercle\
(A) Distribution of genetically labeled DA neurons with Vglut2--Cre (dark blue), Sox6--FSF--Cre (yellow), Cck--Cre (cyan) and Aldh1a1--CreER^T2^ (red) (each dot = 3 neurons). (B) Example of a Cck--Cre;Th--2A--Flpo mouse injected with AAV--CreON,FlpON--EYFP. EYFP+ cells either colocalized with SOX6 or OTX2 (arrowheads). (C) Example of a Sox6--FSF--Cre;Th--2AvFlpo mouse injected with AAV--CreON,FlpON--EYFP. In this mouse, EYFP+ cells colocalize only with SOX6 (white arrowhead) and not with OTX2. (D) Example of a Vglut2--Cre;Th--2A--Flpo mouse injected in the VTA with AAV--CreON,FlpON--EYFP. EYFP+ cells mostly express OTX2 (white arrowhead) and very few cells express SOX6. (E) An example of Aldh1a1--CreER^T2^ injected in the VTA with AAV--CreON--EYFP. EYFP+ cells are OTX2+ and SOX6--. (F) Projections of molecularly defined DA neurons to the nucleus accumbens at different rostral (ACBr), intermediate (ACBi), and caudal (ACBc) levels. Representative images are shown for Sox6--FSF--Cre (G), Aldh1a1--CreER^T2^ (H), Vglut2--Cre (I), and Cck--Cre (J) experiments. See [Table S1](#SD2){ref-type="supplementary-material"} for number of animal replicates for each experiment. Scale bars: B-E low mag. = 200 μm, high mag. = 30 μm; G-J = 200 μm.](nihms-977239-f0004){#F4}

![Dopamine neuron subtype projections to the amygdala\
(A) Projections to the amygdala, as observed in Dat--ires--Cre;Th--2A--Flpo;Ai65 brains. (B) Distribution of DA neuron subtypes found to project to the amygdala labeled by Vip--Cre (red), Vglut2--Cre (blue), and Cck--Cre (green). (C) Labeled neurons in the Vip--Cre;Th--2A--Flpo;Ai65. (D) Labeled neurons by intersectional viral injections in the SNc of the Vglut2--Cre;Th--2A--Flpo. (E) EYFP+ labeled neurons by an injection in the VTA of a Cck--Cre;Th--2A--Flpo mouse. (F) Projections of molecularly defined DA neurons labeled with Vip--Cre (red), Vglut2--Cre (blue), and Cck--Cre (green). (G-I) Representative images from the experiments described above (See [Table S1](#SD2){ref-type="supplementary-material"} for number of animal replicates for each experiment). Scale bars: A = 100 μm; C-E = 200 μm; G-I = 100 μm.](nihms-977239-f0005){#F5}

![Dopamine neuron subtype projections to other brain regions\
Intersectional genetic Strategy I with Dat--ires--Cre revealed DAergic projections to (A) the prefrontal cortex (PFC), (B) the lateral septum (LS), (C) the bed nucleus of the stria terminalis (BST) and (D) the entorhinal cortex (ENT). Using Strategy II in the VTA of Cck--Cre;Th--2A--Flpo mice we observed also an innervation of the PFC (E), LS (F), BST (G) and ENT (H). (I) EYFP+ fibers are observed in the PFC of Vglut2--Cre;Th--2A--Flpo mice after injection of AAV--CreON,FlpON--EYFP in the VTA. (J) EYFP+ fibers are observed in the LS of Vglut2--Cre;Th--2A--Flpo after injection of AAV--CreON,FlpON--EYFP in the VTA. (K) tdTomato+ fibers are observed in the BST of Vip--Cre;Th--2A--Flpo;Ai65 brains. (L) EYFP+ fibers are observed in the ENT of Vglut2--Cre;Th--2A--Flpo after injection of AAV--CreON,FlpON--EYFP in the VTA. See [Table S1](#SD2){ref-type="supplementary-material"} for number of animal replicates for each experiment. Scale bar: A-L = 100 μm.](nihms-977239-f0006){#F6}

![Remarkable specificity of genetically-defined dopamine neuron subtype projections within target regions\
Top caption shows the approximate distribution of DA subtypes analyzed in this study. *Vglut2+*/*Calb1*+ DA neurons located in the SNc (brown) project most densely to the tail of the caudate putamen (CPt) extending ventrally to the capsular region of the amygdala (not depicted). *Sox6*+/*Aldh1a1*+ DA neurons of the SNc (red) project mainly to the rostral and intermediate caudate putamen (CPr and CPi respectively). Within the CP, *Aldh1a1*+ fibers are mainly observed in the dorsolateral region. The *Calb1*+/Sox6+ population of the SNc and dorsolateral VTA (green) send projections to the medial CPr and ventromedial CPi and CPc. This population also contributes projections to the lateral shell and core region of the nucleus accumbens. In the VTA, *Aldh1a1*+ DA neurons (red), which are also *Cck*+/*Vglut2*+, project to the medial shell of the ACB, olfactory tubercle (OT) and lateral septum (LS). *Cck*+/*Vglut2*+ (dark blue), but *Aldh1a1*-, contribute to the prefrontal (PFC) and entorhinal (ENT) cortices as well as the BLA. Finally, a *Vip*+ DA neuron population (purple) located in the dorsal raphe (DR) and periaqueductal gray (PAG) sends projections to the lateral part of the central amygdala (CEA) and the oval nucleus of the bed nucleus of the stria terminalis (BST). The *Slc32a1*+ subtype from Poulin et al. and La Manno et al. was not analyzed due to lack of unambiguous access.](nihms-977239-f0007){#F7}
